| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |